Final Results of Changed Circumstances Review for Bulk Aspirin from the People's Republic of China

Summary

The US Department of Commerce has concluded its review of bulk aspirin imports from China, determining that Jilin Henghe Pharmaceutical is the rightful successor to Jilin Pharmaceutical Company Ltd. and Jilin Pharmaceutical Import and Export Corporation.